Insider trade

Prokidney (PROK): Director sold ~$129K

Brian Jg Pereira, Director at Prokidney, sold ~$129K of Prokidney shares.

~$129K
Approx. value · 54K sh @ $2.37
Traded
Nov 13, 2025
Filed
Nov 14, 2025

What stands out in this filing

  • The sale emptied this holding: the filing reports no shares left in it afterwards.
  • 54,333 shares at an average of $2.37 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 17, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
  2. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
  3. Nov 12, 2025Insider · 1 personInsiders: 2 sales (~$695K)
  4. Nov 13, 2025 · this disclosureInsiderDirector sold ~$129K of PROK shares in the open market

What came next

  1. Nov 13, 2025InsiderDirector sold ~$1.06M of PROK shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Prokidney

For Prokidney, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PROK page.

Other recent filings by Brian Jg Pereira, Director

The full history of Brian Jg Pereira, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Prokidney (PROK) insider traded, and how much?

Brian Jg Pereira, Director at Prokidney, sold ~$129K of Prokidney shares. 54K shares at $2.37.

When did it happen, and when was it made public?

Traded: Nov 13, 2025. Filed: Nov 14, 2025. That is 1 day between the two dates.

What stands out in this filing?

The sale emptied this holding: the filing reports no shares left in it afterwards. 54,333 shares at an average of $2.37 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Prokidney recently?

For Prokidney, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the PROK page.

Does this mean PROK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Prokidney

Everything OQRO holds on this company is on its PROK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data